Status:

COMPLETED

Laparoscopic IIeocecus-Sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon

Lead Sponsor:

Zhejiang University

Conditions:

Hepatic Flexure Colon Cancer

Proximal Transverse Colon Cancer

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

To investigate whether laparoscopic ileocecus-sparing right hemicolectomy is feasible and oncologically safe

Detailed Description

Our study is a single arm, single center clinical trial. The enrolled patients will accept laparoscopic ileocecus-sparing right hemicolectomy. The primary endpoint: postoperative complications, 1-year...

Eligibility Criteria

Inclusion

  • Patients suitable for curative surgery 18-75years old
  • ASA grade I-III
  • Qualitative diagnosis: a pathological diagnosis of adenocarcinoma;
  • Localization diagnosis: the tumor located at hepatic flexure and proximal transverse colon(proximal to the right branch of middle colic artery);
  • Enhanced CT scan of chest, abdominal and pelvic cavity: assessment of tumor stage is T1-T4N0 or TanyN+; there is no distant metastasis.
  • Intraoperative measurement: the distance between colic branch of ileocolic artery and proximal edge of the tumor should be longer than 5cm.
  • Informed consent

Exclusion

  • Simultaneous or metachronous multiple primary colorectal cancer;
  • History of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.
  • Preoperative imaging examination results show: fused lymph node at the root of ileocolic artery.
  • Distant metastasis.
  • History of any other malignant tumor in recent 5 years.
  • Patients need emergency operation.
  • Not suitable for laparoscopic surgery (i.e., extensive adhesion caused by abdominal surgery, not suitable for artificial pneumoperitoneum, etc).
  • Informed consent refusal

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2023

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04479111

Start Date

January 1 2020

End Date

January 1 2023

Last Update

February 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Second Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, China, 310000